Lea Kiefer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lea Kiefer has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Daniele Canzio
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA
4 shared publications - Michael H. Mui
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA
4 shared publications Adan Horta
Pura Vida Investments, New York, NY 10106, USA
3 shared publications- Gabrielle Isabelle F. Servito
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA
3 shared publications - Jennifer Langen
Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA 94158, USA
3 shared publications - Matthew D. Simon
Yale University
3 shared publications
Latest Publications
- Open Access
Engineered Allosteric Control Enhances Specificity and Potency of CRISPR-CasX-based Epigenetic Repressors
Summary: CRISPR-based epigenetic editing enables durable and reversible control of gene expression, overcoming the transient nature of RNA interference and antisense oligonucleotides while avoiding the permanent DNA alterations of other CRISPR-based approaches. Current epigenome editors that fuse the DNMT3A catalytic domain to a DNA-binding module such as catalytically inactive Cas9 deposit CpG methylation to silence gene transcription, but can exhibit off-target activity, cellular toxicity, and transcriptome-wide perturbations due to unconstrained methyltransferase activity. In contrast, DNMT3A regulation in its native context involves autoinhibition of its catalytic activity by its ATRX-DNMT3A-DNMT3L (ADD) domain, which is relieved only upon allosteric activation through recognition of unmodified H3K4 (H3K4me0). Here, we engineered this endogenous allosteric control into CRISPR-based epigenetic editors by designing compact Epigenetic Long Term CasX-based Repressors (ELXRs) containing an allosterically-gated DNMT3A. Allosteric ELXR substantially reduced off-target methylation, rescued dose-dependent growth defects in methylation-sensitive systems, and maintained or enhanced on-target activity across multiple loci (on average ≥4-fold increased activity). We find that integration of DNMT3A allostery is more effective within the CasX framework than with Cas9-based systems, indicating that the increased precision targeting of CasX may be required for the allosteric gate to reduce off-target effects. Mechanistically, the engineered allostery establishes a multi-step gating process in which DNMT3A activation and subsequent CpG methylation occur only after conversion of H3K4me3 to H3K4me0, which we establish requires potentiation by a transcriptional repressor domain. Targeted mutagenesis of ADD confirms this allosteric mechanism in ELXRs matches endogenous DNMT3A regulation. Transcriptome-wide profiling further demonstrated substantially improved specificity with allosteric ELXRs, which were found to reduce the number of differentially expressed genes by 10-100-fold compared with their non-allosteric counterparts. In vivo , lipid nanoparticle delivery of ELXRs achieved potent, durable PCSK9 silencing with precise on-target promoter methylation and minimal off-target transcriptional effects. To date, CRISPR specificity has been governed primarily by gRNA-DNA interactions. By synthetically reconstructing DNMT3A’s allosteric control, we introduce a new regulatory layer that enhances the fidelity and specificity of CRISPR-based epigenetic editing and establishes a general framework for engineering more precise CRISPR-based therapeutics.
Open AccessEngineered Allosteric Control Enhances Specificity and Potency of CRISPR-CasX-based Epigenetic Repressors
Summary: CRISPR-based epigenetic editing enables durable and reversible control of gene expression, overcoming the transient nature of RNA interference and antisense oligonucleotides while avoiding the permanent DNA alterations of other CRISPR-based approaches. Current epigenome editors that fuse the DNMT3A catalytic domain to a DNA-binding module such as catalytically inactive Cas9 deposit CpG methylation to silence gene transcription, but can exhibit off-target activity, cellular toxicity, and transcriptome-wide perturbations due to unconstrained methyltransferase activity. In contrast, DNMT3A regulation in its native context involves autoinhibition of its catalytic activity by its ATRX-DNMT3A-DNMT3L (ADD) domain, which is relieved only upon allosteric activation through recognition of unmodified H3K4 (H3K4me0). Here, we engineered this endogenous allosteric control into CRISPR-based epigenetic editors by designing compact Epigenetic Long Term CasX-based Repressors (ELXRs) containing an allosterically-gated DNMT3A. Allosteric ELXR substantially reduced off-target methylation, rescued dose-dependent growth defects in methylation-sensitive systems, and maintained or enhanced on-target activity across multiple loci (on average ≥4-fold increased activity). We find that integration of DNMT3A allostery is more effective within the CasX framework than with Cas9-based systems, indicating that the increased precision targeting of CasX may be required for the allosteric gate to reduce off-target effects. Mechanistically, the engineered allostery establishes a multi-step gating process in which DNMT3A activation and subsequent CpG methylation occur only after conversion of H3K4me3 to H3K4me0, which we establish requires potentiation by a transcriptional repressor domain. Targeted mutagenesis of ADD confirms this allosteric mechanism in ELXRs matches endogenous DNMT3A regulation. Transcriptome-wide profiling further demonstrated substantially improved specificity with allosteric ELXRs, which were found to reduce the number of differentially expressed genes by 10-100-fold compared with their non-allosteric counterparts. In vivo , lipid nanoparticle delivery of ELXRs achieved potent, durable PCSK9 silencing with precise on-target promoter methylation and minimal off-target transcriptional effects. To date, CRISPR specificity has been governed primarily by gRNA-DNA interactions. By synthetically reconstructing DNMT3A’s allosteric control, we introduce a new regulatory layer that enhances the fidelity and specificity of CRISPR-based epigenetic editing and establishes a general framework for engineering more precise CRISPR-based therapeutics.
- 26 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 385 (6707) , eadm9802
Tuning cohesin trajectories enables differential readout of the Pcdhα cluster across neurons
Expression of Protocadherin (Pcdh) genes is critical to the generation of neuron identity and wiring of the nervous system. Pcdhα genes are arranged in clusters and exhibit a range of expression profiles, from stochastic to deterministic. Because Pcdhα promoters have high sequence identity and share distal enhancers, how distinct neurons choose which gene to express remains unclear. We show that the interplay between multiple enhancers, epigenetics, and genome folding orchestrates differential readouts of the locus across neurons. The probability of Pcdhα promoter choice depends on enhancer/promoter encounters catalyzed by cohesin, whose extrusion trajectories determine the likelihood that an individual promoter can “escape” heterochromatin-mediated silencing. We propose that tunable locus-specific regulatory elements and cell type–specific cohesin activity underlie the generation of cellular diversity by Pcdh genes.
- 26 July 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 385 (6707) , eadm9802
Tuning cohesin trajectories enables differential readout of the Pcdhα cluster across neurons
Expression of Protocadherin (Pcdh) genes is critical to the generation of neuron identity and wiring of the nervous system. Pcdhα genes are arranged in clusters and exhibit a range of expression profiles, from stochastic to deterministic. Because Pcdhα promoters have high sequence identity and share distal enhancers, how distinct neurons choose which gene to express remains unclear. We show that the interplay between multiple enhancers, epigenetics, and genome folding orchestrates differential readouts of the locus across neurons. The probability of Pcdhα promoter choice depends on enhancer/promoter encounters catalyzed by cohesin, whose extrusion trajectories determine the likelihood that an individual promoter can “escape” heterochromatin-mediated silencing. We propose that tunable locus-specific regulatory elements and cell type–specific cohesin activity underlie the generation of cellular diversity by Pcdh genes.
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 380 (6651) , 1236-+
WAPL functions as a rheostat of Protocadherin isoform diversity that controls neural wiring
Neural type–specific expression of clustered Protocadherin (Pcdh) proteins is essential for the establishment of connectivity patterns during brain development. In mammals, deterministic expression of the same Pcdh isoform promotes minimal overlap of tiled projections of serotonergic neuron axons throughout the brain, while stochastic expression of Pcdh genes allows for convergence of tightly packed, overlapping olfactory sensory neuron axons into targeted structures. How can the same gene locus generate opposite transcriptional programs that orchestrate distinct spatial arrangements of axonal patterns? Here, we reveal that cell type–specific Pcdh expression and axonal behavior depend on the activity of cohesin and its unloader, WAPL (wings apart–like protein homolog). While cohesin erases genomic-distance biases in Pcdh choice, WAPL functions as a rheostat of cohesin processivity that determines Pcdh isoform diversity.
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 380 (6651) , 1236-+
WAPL functions as a rheostat of Protocadherin isoform diversity that controls neural wiring
Neural type–specific expression of clustered Protocadherin (Pcdh) proteins is essential for the establishment of connectivity patterns during brain development. In mammals, deterministic expression of the same Pcdh isoform promotes minimal overlap of tiled projections of serotonergic neuron axons throughout the brain, while stochastic expression of Pcdh genes allows for convergence of tightly packed, overlapping olfactory sensory neuron axons into targeted structures. How can the same gene locus generate opposite transcriptional programs that orchestrate distinct spatial arrangements of axonal patterns? Here, we reveal that cell type–specific Pcdh expression and axonal behavior depend on the activity of cohesin and its unloader, WAPL (wings apart–like protein homolog). While cohesin erases genomic-distance biases in Pcdh choice, WAPL functions as a rheostat of cohesin processivity that determines Pcdh isoform diversity.
- Open Access
Improving the study of RNA dynamics through advances in RNA-seq with metabolic labeling and nucleotide-recoding chemistry
RNA metabolic labeling using 4-thiouridine (s 4 U) captures the dynamics of RNA synthesis and decay. The power of this approach is dependent on appropriate quantification of labeled and unlabeled sequencing reads, which can be compromised by the apparent loss of s 4 U-labeled reads in a process we refer to as dropout. Here we show that s 4 U-containing transcripts can be selectively lost when RNA samples are handled under sub-optimal conditions, but that this loss can be minimized using an optimized protocol. We demonstrate a second cause of dropout in nucleotide recoding and RNA sequencing (NR-seq) experiments that is computational and downstream of library preparation. NR-seq experiments involve chemically converting s 4 U from a uridine analog to a cytidine analog and using the apparent T-to-C mutations to identify the populations of newly synthesized RNA. We show that high levels of T-to-C mutations can prevent read alignment with some computational pipelines, but that this bias can be overcome using improved alignment pipelines. Importantly, kinetic parameter estimates are affected by dropout independent of the NR chemistry employed, and all chemistries are practically indistinguishable in bulk, short-read RNA-seq experiments. Dropout is an avoidable problem that can be identified by including unlabeled controls, and mitigated through improved sample handing and read alignment that together improve the robustness and reproducibility of NR-seq experiments.
Open AccessImproving the study of RNA dynamics through advances in RNA-seq with metabolic labeling and nucleotide-recoding chemistry
RNA metabolic labeling using 4-thiouridine (s 4 U) captures the dynamics of RNA synthesis and decay. The power of this approach is dependent on appropriate quantification of labeled and unlabeled sequencing reads, which can be compromised by the apparent loss of s 4 U-labeled reads in a process we refer to as dropout. Here we show that s 4 U-containing transcripts can be selectively lost when RNA samples are handled under sub-optimal conditions, but that this loss can be minimized using an optimized protocol. We demonstrate a second cause of dropout in nucleotide recoding and RNA sequencing (NR-seq) experiments that is computational and downstream of library preparation. NR-seq experiments involve chemically converting s 4 U from a uridine analog to a cytidine analog and using the apparent T-to-C mutations to identify the populations of newly synthesized RNA. We show that high levels of T-to-C mutations can prevent read alignment with some computational pipelines, but that this bias can be overcome using improved alignment pipelines. Importantly, kinetic parameter estimates are affected by dropout independent of the NR chemistry employed, and all chemistries are practically indistinguishable in bulk, short-read RNA-seq experiments. Dropout is an avoidable problem that can be identified by including unlabeled controls, and mitigated through improved sample handing and read alignment that together improve the robustness and reproducibility of NR-seq experiments.
- Top Cited PapersOpen Access
Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Background: Chronic inducible urticaria (CIndU) is characterized by mast cell (MC)‐mediated wheals in response to triggers: cold in cold urticaria (ColdU) and friction in symptomatic dermographism (SD). KIT receptor activation by stem cell factor (SCF) is essential for MC function. Barzolvolimab (CDX‐0159) is a humanized antibody that inhibits KIT activation by SCF and was well tolerated in healthy volunteers with dose‐dependent plasma tryptase suppression indicative of systemic mast cell ablation.Methods: This is an open‐label, trial in patients with antihistamine refractory ColdU or SD, receiving one IV dose of barzolvolimab (3 mg/kg), with a 12‐week follow‐up. Primary endpoint was safety/tolerability; pharmacodynamic (PD)/clinical endpoints included serum tryptase, plasma SCF, skin MC histology, provocation tests, urticaria control test (UCT), and dermatology life quality index (DLQI).Results: Analysis populations were safety (n = 21) and pharmacodynamics/clinical activity (n = 20). Barzolvolimab was well tolerated; most adverse events were mild and resolved. Treatment resulted in significant depletion of skin MCs, decreased tryptase (n = 19/20) of patients (n = 10/10 ColdU; n = 9/10 SD), and all (n = 20/20) showed improvement in urticaria control (UCT ≥ 12). The kinetics of clinical activity mirrored that of MC and tryptase reduction. DLQI‐measured impairment significantly decreased to minimal/none in 93% of patients on study.Conclusion: In CIndU patients, barzolvolimab was well tolerated, demonstrated marked, rapid, durable depletion of skin MCs, circulating tryptase, and reductions in clinical activity with significant improvements in disease control and quality of life (QoL) demonstrating potential therapeutic effects for MC‐mediated disorders.
Top Cited PapersOpen AccessAnti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
Background: Chronic inducible urticaria (CIndU) is characterized by mast cell (MC)‐mediated wheals in response to triggers: cold in cold urticaria (ColdU) and friction in symptomatic dermographism (SD). KIT receptor activation by stem cell factor (SCF) is essential for MC function. Barzolvolimab (CDX‐0159) is a humanized antibody that inhibits KIT activation by SCF and was well tolerated in healthy volunteers with dose‐dependent plasma tryptase suppression indicative of systemic mast cell ablation.Methods: This is an open‐label, trial in patients with antihistamine refractory ColdU or SD, receiving one IV dose of barzolvolimab (3 mg/kg), with a 12‐week follow‐up. Primary endpoint was safety/tolerability; pharmacodynamic (PD)/clinical endpoints included serum tryptase, plasma SCF, skin MC histology, provocation tests, urticaria control test (UCT), and dermatology life quality index (DLQI).Results: Analysis populations were safety (n = 21) and pharmacodynamics/clinical activity (n = 20). Barzolvolimab was well tolerated; most adverse events were mild and resolved. Treatment resulted in significant depletion of skin MCs, decreased tryptase (n = 19/20) of patients (n = 10/10 ColdU; n = 9/10 SD), and all (n = 20/20) showed improvement in urticaria control (UCT ≥ 12). The kinetics of clinical activity mirrored that of MC and tryptase reduction. DLQI‐measured impairment significantly decreased to minimal/none in 93% of patients on study.Conclusion: In CIndU patients, barzolvolimab was well tolerated, demonstrated marked, rapid, durable depletion of skin MCs, circulating tryptase, and reductions in clinical activity with significant improvements in disease control and quality of life (QoL) demonstrating potential therapeutic effects for MC‐mediated disorders.
- Open Access
Cohesin erases genomic-proximity biases to drive stochastic Protocadherin expression for proper neural wiring
Clustered Protocadherin (Pcdh) proteins act as cell-surface recognition barcodes for neural circuit formation. Neurites expressing the same barcode repel each other, but this mechanism is deployed in two different ways. For instance, convergence of olfactory sensory neuron (OSN) projections requires stochastic expression of distinct Pcdh isoforms in individual cells, while tiling of neural arbors of serotonergic neurons (5-HTs) requires expression of the same isoform, Pcdhαc2. Despite their essential role, however, the molecular mechanisms of cell-type specific Pcdh barcoding remain a mystery. Here, we uncover a new role of cohesin: that of regulating distance-independent enhancer-promoter interactions to enable random Pcdh isoform choice via DNA loop extrusion in OSNs. Remarkably, this step mediates DNA demethylation of Pcdh promoters and their CTCF binding sites, thus directing CTCF to the chosen promoter. In contrast, the uniform pattern of Pcdh expression in 5-HTs is achieved through conventional cohesin-independent, distance-dependent enhancer/promoter interactions, that favor choice of the nearest isoform. Thus, cell-type specific cohesin deployment converts a distance-dependent and deterministic regulatory logic into a distance-independent and stochastic one. We propose that this mechanism provides an elegant strategy to achieve distinct patterns of Pcdh expression that generate wiring instructions to meet the connectivity requirements of different neural classes.
Open AccessCohesin erases genomic-proximity biases to drive stochastic Protocadherin expression for proper neural wiring
Clustered Protocadherin (Pcdh) proteins act as cell-surface recognition barcodes for neural circuit formation. Neurites expressing the same barcode repel each other, but this mechanism is deployed in two different ways. For instance, convergence of olfactory sensory neuron (OSN) projections requires stochastic expression of distinct Pcdh isoforms in individual cells, while tiling of neural arbors of serotonergic neurons (5-HTs) requires expression of the same isoform, Pcdhαc2. Despite their essential role, however, the molecular mechanisms of cell-type specific Pcdh barcoding remain a mystery. Here, we uncover a new role of cohesin: that of regulating distance-independent enhancer-promoter interactions to enable random Pcdh isoform choice via DNA loop extrusion in OSNs. Remarkably, this step mediates DNA demethylation of Pcdh promoters and their CTCF binding sites, thus directing CTCF to the chosen promoter. In contrast, the uniform pattern of Pcdh expression in 5-HTs is achieved through conventional cohesin-independent, distance-dependent enhancer/promoter interactions, that favor choice of the nearest isoform. Thus, cell-type specific cohesin deployment converts a distance-dependent and deterministic regulatory logic into a distance-independent and stochastic one. We propose that this mechanism provides an elegant strategy to achieve distinct patterns of Pcdh expression that generate wiring instructions to meet the connectivity requirements of different neural classes.
- Open Access
- 9 March 2022
- Published by Springer Nature in Research Square
Cohesin erases genomic-proximity biases to drive stochastic Protocadherin expression for proper neural wiring
Clustered Protocadherin (Pcdh) proteins act as cell-surface recognition barcodes for neural circuit formation. Neurites expressing the same barcode repel each other, but this mechanism is deployed in two different ways. For instance, convergence of olfactory sensory neuron (OSN) projections requires stochastic expression of distinct Pcdh isoforms in individual cells, while tiling of neural arbors of serotonergic neurons (5-HTs) requires expression of the same isoform, Pcdhαc2. Despite their essential role, however, the molecular mechanisms of cell-type specific Pcdh barcoding remain a mystery. Here, we uncover a new role of cohesin: that of regulating distance-independent enhancer-promoter interactions to enable random Pcdh isoform choice via DNA loop extrusion in OSNs. Remarkably, this step mediates DNA demethylation of Pcdh promoters and their CTCF binding sites, thus directing CTCF to the chosen promoter. In contrast, the uniform pattern of Pcdh expression in 5-HTs is achieved through conventional cohesin-independent, distance-dependent enhancer/promoter interactions, that favor choice of the nearest isoform. Thus, cell-type specific cohesin deployment converts a distance-dependent and deterministic regulatory logic into a distance-independent and stochastic one. We propose that this mechanism provides an elegant strategy to achieve distinct patterns of Pcdh expression that generate wiring instructions to meet the connectivity requirements of different neural classes.
- 9 March 2022
- Published by Springer Nature in Research Square
Open AccessCohesin erases genomic-proximity biases to drive stochastic Protocadherin expression for proper neural wiring
Clustered Protocadherin (Pcdh) proteins act as cell-surface recognition barcodes for neural circuit formation. Neurites expressing the same barcode repel each other, but this mechanism is deployed in two different ways. For instance, convergence of olfactory sensory neuron (OSN) projections requires stochastic expression of distinct Pcdh isoforms in individual cells, while tiling of neural arbors of serotonergic neurons (5-HTs) requires expression of the same isoform, Pcdhαc2. Despite their essential role, however, the molecular mechanisms of cell-type specific Pcdh barcoding remain a mystery. Here, we uncover a new role of cohesin: that of regulating distance-independent enhancer-promoter interactions to enable random Pcdh isoform choice via DNA loop extrusion in OSNs. Remarkably, this step mediates DNA demethylation of Pcdh promoters and their CTCF binding sites, thus directing CTCF to the chosen promoter. In contrast, the uniform pattern of Pcdh expression in 5-HTs is achieved through conventional cohesin-independent, distance-dependent enhancer/promoter interactions, that favor choice of the nearest isoform. Thus, cell-type specific cohesin deployment converts a distance-dependent and deterministic regulatory logic into a distance-independent and stochastic one. We propose that this mechanism provides an elegant strategy to achieve distinct patterns of Pcdh expression that generate wiring instructions to meet the connectivity requirements of different neural classes.
- Open Access
Multi-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies
Somatic mutations in splicing factors are of significant interest in myeloid malignancies and other cancers. U2AF1, together with U2AF2, is essential for 3’ splice site recognition. U2AF1 mutations result in aberrant splicing, but the molecular mechanism and the full spectrum of consequences on RNA biology have not been fully elucidated to date. We performed multi-omics profiling of in vivo RNA binding, splicing and turnover for U2AF1 S34F and Q157R mutants. We dissected specific binding signals of U2AF1 and U2AF2 and showed that U2AF1 mutations individually alter U2AF1-RNA binding, resulting in defective U2AF2 recruitment. We demonstrated a complex relationship between differential binding and splicing, expanding upon the currently accepted loss-of-binding model. Finally, we observed that U2AF1 mutations increase the formation of stress granules in both cell lines and primary acute myeloid leukemia samples. Our results uncover U2AF1 mutation-dependent pathogenic RNA mechanisms and provide the basis for developing targeted therapeutic strategies.
Open AccessMulti-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies
Somatic mutations in splicing factors are of significant interest in myeloid malignancies and other cancers. U2AF1, together with U2AF2, is essential for 3’ splice site recognition. U2AF1 mutations result in aberrant splicing, but the molecular mechanism and the full spectrum of consequences on RNA biology have not been fully elucidated to date. We performed multi-omics profiling of in vivo RNA binding, splicing and turnover for U2AF1 S34F and Q157R mutants. We dissected specific binding signals of U2AF1 and U2AF2 and showed that U2AF1 mutations individually alter U2AF1-RNA binding, resulting in defective U2AF2 recruitment. We demonstrated a complex relationship between differential binding and splicing, expanding upon the currently accepted loss-of-binding model. Finally, we observed that U2AF1 mutations increase the formation of stress granules in both cell lines and primary acute myeloid leukemia samples. Our results uncover U2AF1 mutation-dependent pathogenic RNA mechanisms and provide the basis for developing targeted therapeutic strategies.
- Open Access
- 28 March 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (14) , 1833-1834
Stella’s Role in Oocyte DNA Methylation Suggests Additional Activities of DNMT1
- 28 March 2019
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 58 (14) , 1833-1834
Open AccessStella’s Role in Oocyte DNA Methylation Suggests Additional Activities of DNMT1